VIP
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
VIP
Vasoactive Intestinal Peptide · VIP · P01282
Contact us for current batch testing data on this specification.

VIP (vasoactive intestinal peptide) is a 28-residue C-terminally amidated neuropeptide of the secretin/glucagon family and a laboratory ligand for VPAC1 and VPAC2 receptors.(VIP)
Overview
VIP was first isolated from porcine intestine as a 28-amino acid peptide, conserved in sequence between most mammals. It belongs to the secretin/glucagon superfamily and is used as a laboratory reference ligand at VPAC1 and VPAC2.
Each lot is HPLC-purified and mass-confirmed. Identity, purity and net peptide content are recorded on the COA. The material is the C-terminally amidated 28-mer matching the mature human sequence.
What is VIP?
VIP (vasoactive intestinal peptide) is a single-chain, 28-residue neuropeptide. Said and Mutt isolated it from porcine small intestine in 1970; the amino-acid sequence of the porcine octacosapeptide was reported in 1974. Human, porcine and rat mature VIP are identical. The peptide is processed from a larger precursor encoded by the VIP gene and is C-terminally amidated. It is supplied here as a lyophilized laboratory reference, not as a medicine.
Why purity matters
Each batch is HPLC-purified and mass-confirmed, with identity, purity and net peptide content documented on the COA. The intact mass should match the amidated 28-mer. Met17 is a known oxidation site; lots are stored dry and protected from oxidants.
Key Highlights
- HPLC purity ≥ 99% with a Certificate of Analysis (COA) per batch
- Identity confirmed by LC-MS; net peptide content reported
- Available packaging: 10mg*10vials
- Lyophilized powder; custom packaging and labeling available
- For laboratory research use only — not for human or veterinary use
Safety & Side Effects
VIP (vasoactive intestinal peptide) is a 28-residue C-terminally amidated neuropeptide of the secretin/glucagon family and a laboratory ligand for VPAC1 and VPAC2 receptors.(VIP) When used in research, VIP should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.
Published vip side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for neurological and neuroprotective pathways readouts and any off-target effects relevant to the compound’s mechanism when designing a study.
For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.
Dosage & Protocol
There is no standardized human dosage for VIP; it is supplied strictly for laboratory research. Reported vip dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.
Research protocols typically document vip dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 40077-57-4, molecular formula C147H238N44O42S, molecular weight 3325.8 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.
Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.
Comparison
| 列 1 | 列 2 | 列 3 |
|---|---|---|
| VIP | VPAC1 / VPAC2 | 28-residue amidated secretin-family neuropeptide |
| PACAP-38 | PAC1 / VPAC1 / VPAC2 | PACAP; PAC1-preferring relative to VIP |
| Secretin | Secretin receptor | 27-residue related peptide |
| Glucagon | GCGR | 29-residue related peptide |
How to Order
Enquiry
Send product code, strength and quantity for a fast quote.
Quotation
Receive price, lead time and specification.
QC & COA
Batch tested by HPLC/LC-MS; COA issued.
Delivery
Discreet, tracked worldwide shipping.
Specifications
| Product name | VIP |
|---|---|
| Product code | VP10 |
| Specification | 10mg*10vials |
| CAS number | 40077-57-4 |
| Molecular formula | C147H238N44O42S |
| Molecular weight | 3325.8 g/mol |
| Purity | ≥99% |
| Category | Neurological |
| Appearance | White lyophilized powder |
| Salt form | Acetate / TFA (on request) |
| Packaging | 10mg*10vials |
| Documentation | COA, MSDS on request |
Applications
Packaging & Shipping
Available pack sizes
Shipping
Storage & Handling
Store lyophilized powder sealed at −20 °C, protected from light and moisture. Allow vials to reach room temperature before opening. Once reconstituted, keep refrigerated and avoid repeated freeze–thaw cycles.
Product Information Q&A
What purity is your VIP?
Each batch is third-party tested for identity and purity. HPLC and mass-spectrometric results are listed on the COA.
What pack sizes are available?
Available options include: 10mg*10vials. Custom packaging is available on request.
Can I order bulk quantities?
Yes. We supply from research samples to bulk orders with scalable manufacturing and stable supply.
Is this product for human use?
No. All products are supplied strictly for laboratory research use and are not intended for human or veterinary use.
How is it shipped?
Discreetly and with tracking via optimized worldwide logistics, with appropriate packaging to protect integrity.

